Hologic’s HOLX fully automated, high-throughput Panther platform remains the foundation of its molecular diagnostics business. The Panther Fusion module, a 2016 addition to the base system, provides ...
New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care Hologic, Inc. (Nasdaq: HOLX) ...
Hologic has won clearance for the Panther Fusion Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The Marlborough, MA-based company said it has also obtained CE marking in accordance ...
Hologic Inc. HOLX Breast Health segment is likely to have witnessed strong performance owing to increased sales of its interventional breast solutions products driven by Brevera systems and related ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results